ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001145.1|Cyclothiazomycin_1 # 1 # 1911 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.785	BGC0001145.1|Cyclothiazomycin_1 	1	1911	+	Loose	500	28.4906	OXA-85	26.03	3001780	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCTACCGAAACTGAAGTCCGACGTGCTGTACGTGCCCACTCCCGACGGCGCCCACGTCTTCGGGGCGGGCGCCGACGTCGCGCTGCGCGGGCCGGCCGCCTACCGGCTGCTGGACCGGCTCGCACCGCACCTGGACGGCTCGACCGAACTCGACGCGCTCGTCCGCGGTCTGCCGGACGGCACCCGCACCGCCGTGGAACGGCTGGTCGGACGGCTGCAGTCGGCCGGCTGCCTCATCGACGCGGCCGCGGACCTGCCGCACGGTCTGACCGCCCGGGAACTCGACACGTATGCGGCCGAGATCGCCTTCGTCGAGTACCACGCCACCTCGGCGGCCCGCCGGTTCCAGACCTACCGGGACAGCGCGGTGACGGTGGTCGGCGCGGGACCGGTGTTCACCGCCCTGGTCTGCTCGGCGCTCCGCTCGGGCGTGCGGCGGCTGCGGGCCGTCCACACGCCGGACACGGGCACGGATCCCGCCGCCGACGCGGACCGGCTGACCGAACTGGCCGCCGAGGCGGCGCTCCGCGACCCGGACCAGACGCTGGAGCGGGTGCCGTTCTCGGCGGCGGAGGAGGACCGGCTGGCGACCGCCGACGCGGTGCTGCACGTGGCGGCGGGCCCGGCGGTCGAACGGGCGCCGCGGCTGGACCGGTTGTGCGGCACCTCGGGCACCCTGCTGGTACAGGGCGTGGTGCTCGACGACGTGGCCTGGCTGGGGCCGCCCGGGCCGGACTGGGCGTCGGCCTGGTCGCGGCTGCGCGCCCGGCCGCCGTACCGGACGGGTACGTTCCTGACCGGGCCCGCGGCGGCGGTGGTCGCCGGGCACCTCGGGCTCGCCGCCTTCCGCGCGCTGGCCGGCATCGAGGAGCCGGGCGCGCGGGCCGCGCTGACCCGGATCGACCTCGAGACCCTGCGCACCTCGACGCACGCCTTCCTGCCGCACCCGGCCGCGCGGCCGGCCGGACCGGAGCCGGCGGCGGCGTTCACGGCCCGGATCGGCCGGCTGCGCGCGGCGGCGCCCCTGAGCGCGGAGGAGTTCTCCGCCGCCGCGGCGGCCTGCTTCGACCCGTACACCGGTGTCCTGCGGACCCTGGACGAGGGGGACTTCACCCAGATCCCGCTGCACGTCACCGAAGCGGTCCCGCACCTCGCCGACTCCGGCGGTCCCCGGGTCTTCGGCACGGGACCGGACTTCGCCGAGGCCAGGCGGCGGGCGGCGCTCCGGGGGATCGCCCGGCACGCGGCGGCCTCGCCCGACCCGCGCCGGTTCGGCCCCGGCGCCACGGTGTGGGGCTGGGACCTCGCCGACGGGCAGCCGGTGCGGGTCCCCGCGGACACGGCGTTCTCGGCGGGCACCGGCCTGGCGGCGCGGCTGTCCTGGGACGAGGCGGTGGACGACGGCCTCGGGCAGCACTGCGCCCGGCTGGCGGCCGAGGACGTGGCGGCGGGCCGGACGCGCCCCGTCCCGCTGGACCTCACCCAGGCACCGGCCGACGAGCGGACCGCACGGTACCTCGGCCTGCTGCGGGCCGCCGGCGGCACCGCGCGGGTCGCGGACATCGGTGGCGCGCTCGGTGTACCGGTCCTCGCCTGGTGGCTCGACGGCCGCCCGGTCGCGGTGACCTGCGGCCCGGACGCGGCGGCGGAGGGCCTGGAACGGACCCTGCTGGCGCGCCAGTCGGCGATGACCGACGAGCCGGCGTACGCGCCGGAGCCGGTCCCCGGCCTCGGCGACCCACCGGAACCGGCCCCGACCGCCGCCTGGCCGGCCGCACCGGACCGCGCCGCCCTGCCGGCCGCCCTGCGCTCCCGCGGCCTGCGCCCCGTGGCGGTCCCCTTGGACCACGACCCCGCCGTCCACGACGTCCTCCCGTCCGTGCTCCGGGTCGTGACGGCCGATGCGTGA	MLPKLKSDVLYVPTPDGAHVFGAGADVALRGPAAYRLLDRLAPHLDGSTELDALVRGLPDGTRTAVERLVGRLQSAGCLIDAAADLPHGLTARELDTYAAEIAFVEYHATSAARRFQTYRDSAVTVVGAGPVFTALVCSALRSGVRRLRAVHTPDTGTDPAADADRLTELAAEAALRDPDQTLERVPFSAAEEDRLATADAVLHVAAGPAVERAPRLDRLCGTSGTLLVQGVVLDDVAWLGPPGPDWASAWSRLRARPPYRTGTFLTGPAAAVVAGHLGLAAFRALAGIEEPGARAALTRIDLETLRTSTHAFLPHPAARPAGPEPAAAFTARIGRLRAAAPLSAEEFSAAAAACFDPYTGVLRTLDEGDFTQIPLHVTEAVPHLADSGGPRVFGTGPDFAEARRRAALRGIARHAAASPDPRRFGPGATVWGWDLADGQPVRVPADTAFSAGTGLAARLSWDEAVDDGLGQHCARLAAEDVAAGRTRPVPLDLTQAPADERTARYLGLLRAAGGTARVADIGGALGVPVLAWWLDGRPVAVTCGPDAAAEGLERTLLARQSAMTDEPAYAPEPVPGLGDPPEPAPTAAWPAAPDRAALPAALRSRGLRPVAVPLDHDPAVHDVLPSVLRVVTADA	MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	250.39	gnl|BL_ORD_ID|260|hsp_num:0	289			306	507	cloxacillin; oxacillin; cefalotin
BGC0001145.1|Cyclothiazomycin_2 # 1904 # 3835 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.790	BGC0001145.1|Cyclothiazomycin_2 	1904	3835	+	Loose	550	26.5646	KPC-17	39.66	3002327	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGCGTGACCACGTGCCGGGGACACCGGGGACCGGCGGGGGCGGAGAGAGCGAACGGGCCGGTGCCGCCGCGGGAACGCACTCCGCCGGGCCGCGCCCGCCGACGCCCGGCACCCTCCGGCCCCGACCGGGCACCCCGCCGGCCCGCACCTCGGCCTTTCCGCCGGACGGCCCGGCACCCGTCCGGCCGGAACCCGCGGGGGAGCACGGTCCGTCGGCGGCGGGCGTCCCCGCGGATCCGCCCCCGGGCGCCCCGCCCGGCACCCGGCCGGACGGCCTCGTCCTCCACCCCGCGCATCCGGAAGGCGCGCCTCGCCCCGGTCCGGCGGCCGTTCCGCCCGAGAGCGAGCCCGGCACTCCCGGCCTCCGCTTCTGGTGGCGCACCTTCGAGGGGGTGCGGGAGCTGTTCGCGGAGGGGCAGGGGGCCGAGGGCGGGGACGGGGATCCGCTGCCCGTGAAGACGTACCGCGGGCTGCCGCGGCACGTGCTGAGCCCGCCGGCGCGGCGGATCGGGGACGCGCGGTGGTCCTTCGAGGGCTTCCGCCGGAGCCGGCCCGACGGCGTCCCGGGCCGGGCCGCGCTGGACGAACCGGCCGTGTCCGCCCTGACGCACCACACGTACGGGCTGGCCCGGATCGAGCTGGGGCCGCACGCGTCGTGGCCGTACCACCGCGTCGTCCCGTCCGCCCGCTGCTTCCACCCGGTGGAGCTGTACCTGTGGCTCGCGGCGCCGGCCGGGGAACTGCCCGCCGGCTGCTACCACTTCGATCCCGCGCACCACGCGCTGACCCGGCTGCGCACCGGCGGGATCCCGGCCGCGCTGCACGCCGCCGCGGGCACCGGGCGGGCCGGGGGCGGCACGCTGGCGCTGCTGGTGGCGGCCGTCCACTTCCGTAAGACGGCGTTCCGCTACCGCGACTACGCGTACCGGCTGGGCGCCCAGGAAGCGGGCATGACCGTCGGCAACGCCCTGATGGTCGCGGCGGCGCTGGGCCTGGAGGGGAGGGTCCACCAGCGGTTCGGGGACGCCGTGGTCGACCGGGCGCTGGGCCTGGACGGTACGGAGGAGACCGCGTTCGCCGTGGTCGACCTGTACGGCGCGGCGGGCGGGCCTCCGCCGGGGGCCGGTGTGCCCGAGGCGCCGTTGGGCGTCATCCGGCCGGAGTACGTGCGCACGTGCCACGCCGACGCGGCGGCCTGGTCGGGGCTGACGGCGCTGGACCGCGCGGCCCGGCTGTCCGGTCCGGGCGCCGCGCTGGACACGTCCGCCTTCCACGCGCCGCAGGCCGCCTCCGAGGCCGCGGCCCTGCCCTTGGGCGGCGCGGCGCCCGGCCGGCGGGAGCTGGCGGAGGCGCTGCGCGCCCGGGACTCGGGCGGGCGGATGTTCCTGCCGGCCGACGCCGAGCTGCCCGCCGCCGCCCTGGCGGGGCCGCTGCGGCACGCGCTGGAGCCGGTTCCGTCGGACCACACCGGAGGGCCCCGCCGGCCGCTGGTGGACTGCCACGTCCTCGTCCGGAACGTGGCGGGGGTGCCCGCCGGGCTCTACGGGCTGGACCCCGGGCCCGCGCCCTCCCTGGTCCCGCTCCCCCACCGTGACGGCTCCGCCGTCGTGGCGATGGTCTGCGACCGGACGCCGTCCGTGAACGCGGCCAAGGCCAACGCCCTGGTCTTCCTGACGGTGGACCGGGAGGCGGGCGACCGTGTCCTCGGCCCGCGCGGGTACCGGATCCTGCACCAGGAGGCGGGCGTGGTGGCGCAGCGGATCAGTGTGCTGGCCGCGGCGGAGGGGGTGTCCGCGCGGATCACCAACGGGTACGACGACCGGATGGTCCGCGAGTTGCTCGGCGCCGGCCCGGAGCGGGTGCCCGTCTTCGCCCTCGTCCTCGGCCGCCGCCGGCCCACGGCCCAGTACGAACCGCCGCTGACCTGGTGA	MRDHVPGTPGTGGGGESERAGAAAGTHSAGPRPPTPGTLRPRPGTPPARTSAFPPDGPAPVRPEPAGEHGPSAAGVPADPPPGAPPGTRPDGLVLHPAHPEGAPRPGPAAVPPESEPGTPGLRFWWRTFEGVRELFAEGQGAEGGDGDPLPVKTYRGLPRHVLSPPARRIGDARWSFEGFRRSRPDGVPGRAALDEPAVSALTHHTYGLARIELGPHASWPYHRVVPSARCFHPVELYLWLAAPAGELPAGCYHFDPAHHALTRLRTGGIPAALHAAAGTGRAGGGTLALLVAAVHFRKTAFRYRDYAYRLGAQEAGMTVGNALMVAAALGLEGRVHQRFGDAVVDRALGLDGTEETAFAVVDLYGAAGGPPPGAGVPEAPLGVIRPEYVRTCHADAAAWSGLTALDRAARLSGPGAALDTSAFHAPQAASEAAALPLGGAAPGRRELAEALRARDSGGRMFLPADAELPAAALAGPLRHALEPVPSDHTGGPRRPLVDCHVLVRNVAGVPAGLYGLDPGPAPSLVPLPHRDGSAVVAMVCDRTPSVNAAKANALVFLTVDREAGDRVLGPRGYRILHQEAGVVAQRISVLAAAEGVSARITNGYDDRMVRELLGAGPERVPVFALVLGRRRPTAQYEPPLTW	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	219.45	gnl|BL_ORD_ID|1876|hsp_num:0	2038			516	681	
BGC0001145.1|Cyclothiazomycin_3 # 3995 # 4177 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.678	BGC0001145.1|Cyclothiazomycin_3 	3995	4177	+	Loose	340	21.1718	sta	32.0	3004699	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGGAGGCGAAGCTCGAACTGGACCTCGGCGACCTGAGCGTCGAGGAACTCGACGTGCTGCCCACCTCGCCGGGTGCCGGCCTGGAGTCGATCAACGTCGGCCACGCCATGGTCGAGATCGGCGCGTCCAACTGCACCTCGCGCGGTACGCCCGCGAGCTGCTGCTCCTGTTGCTGCTGCTGA	MEAKLELDLGDLSVEELDVLPTSPGAGLESINVGHAMVEIGASNCTSRGTPASCCSCCCC	MTTTHGSTYEFRSARPGDAEAIEGLDGSFTTSTVFEVDVTGDGFALREVPADPPLVKVFPDDGGSDGEDGAEGEDADSRTFVAVGADGDLAGFAAVSYSAWNQRLTIEDIEVAPGHRGKGIGRVLMRHAADFARERGAGHLWLEVTNVNAPAIHAYRRMGFAFCGLDSALYQGTASEGEHALYMSMPCP	31.75	gnl|BL_ORD_ID|2220|hsp_num:0	3397			312	387	streptothricin
BGC0001145.1|Cyclothiazomycin_4 # 4305 # 6248 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.773	BGC0001145.1|Cyclothiazomycin_4 	4305	6248	+	Loose	600	27.7202	vanJ	38.1	3002914	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanJ membrane protein	GTGACCGACGCCGCTCCGGACGCGCCCCCTCCGGCGGGTGCCGCCGTGCTGGGCAAGGGCCTGCTCGCCACCGCCGTCCGCACCGCCCTCGGCCGCGCCGGCCTCCTGGTCCCCGAGCCGGGCACCGGCCGCTCCGCCGTGGTGACCGTGGACGACGGGTGGAACCCGGCGACGGAACCTGAGGTTCCGGGCGTCCCGTGGCTCCCCGTCCGGGTCGAGCTCGGGACCGTCGTCATCGGGCCGTACGTCGTCCCCGGCCGCCCCGGCTGCGCCCGCTGCGCCCGGACCCGGCGGACCCGCGCCCTCGGCCCGGACAGCCCCCGCGCGGAGCTGGTGCGCCGCCACGGGGACCGGCTGGCCGACCGGGACACGCCGTTGCTGCCCGCGCCGGCGCGCGACACGGTGGCCGCCCTCGTCACCCATGAACTGACCTCCGGCGAACACCGGTTGACCGACCGGGCCGTCCTCATGCTCGCGCTGCCCGCCCTGACGGCCGGCGTCCACCCCTTCCTGCCCGTGCCCGACTGCCCGTCCTGCGGCGGGCTGCCCCCGGACCGGCCGCCCGTCCTCATGGACGTACCGCGCCCCAAGCCGGCCCCGGACGTCCACCGGACCCGCGACCTCGCGGCCGGCTGGGACGCGCTGCGGGACACCTTCGTGGACGGCCGCACCGGCGTGGTGCGCCAGCTCGACGTGCGGACGGACTACCCGTACCCGATGGTGTCGGCCCCCCTCCACCTGCCCGGCGGCGAGCAGGAGGCGGGGTTCGGCCGCGACCTGGACTACGCGTCCTGTGCCCGGACGGCCCTGGCGGAGGCCCTGGAGCGGCTCGGTGGGGCCCGCCCCGGCGGCCGGCGCCCGACCGTACGGGCCCCCTACCGCGACGTCGCCGGACACGCGCTGCACCCGCCGGACCTCGGCCTCTACCCGCCGGAGCGGTACGCGGAACCCGGCTTCCCCTACCCGCCGTTCGACCCCGGCCTCGAACTCTCCTGGGTATGGGGGCACTCCTTCGCCCGCGACGCGCCCGTCCTCGTCCCCGAGGACTACGCCTACTACCGCACCCGGCACGACGGCCCGCACGCCCGGCCGCTGGCCTACGAGGTGTCCAACGGCTGCGCCCTGGGCGGCTGCCTGGAGGAGGCGGCCCTGCACGGGCTGGTGGAGCTGGCGGAGCGGGACGCGTTCCTGCTCACCTGGTACGCCCGGCTGCCCGTCCCCCGGATCGACCTCGGCACCGTGTCCGACCCGCGGATCCCGGTGCTGGCCGAGCGGATCCGGCAGGACGGCGGCCACCGGGTCGTGGCCTTCGCGACCACGCCCGACCACGGCGTCCCCAGCGTCTGGGTGATGGCCGTGCACCCCCGTCCCGGCCGCGAGCCGGCGGCGGTCTGCGCGGCCGGCGCCCACTTCGATCCCGAACGGGCGCTGCTCAACGGCCTGCTGGAGCTCACCGCGAACCTCGGCTGGAACCGGGTGGCGTGGCGCGAGGAGACGGCCCGGATCGCCGCGATGGTCGACGACCCGGAGCTGGTACGGGAGATGCGCGACCACGCGCTGCTCTACTGCCACCCCGCCGCCTTCGACCGCTTCGGCTTCCTGTTCGGCGACGCGCCCGCGCTGCCGGTGCGGGAGGCGTTCGCGCGGGCCGGCCTCCGGCCGCGCGGGGACGACCTCCGCGACGACCTGGCCGAGGTGGTGGCCCGGTTCACCGGCGCCGGACTCGACGTCGTCGTGGTGGACCAGACGACCGACGAGCACCGGGCGGGCGGTTTCGCCTGCGCCAAGGTGATCGTGCCGGGACTGCTGCCGATGACCTTCGGCCACCGGATGCGCCGCACCCACGGCCTGCCGCGCCTCCGCGACCTGCCGGCCCGCCTCGGCCACCGCGCCGGACCGCTGGGCCCGGACGACGTCAATCCGCACCCCCACCCGTTCCCCTGA	MTDAAPDAPPPAGAAVLGKGLLATAVRTALGRAGLLVPEPGTGRSAVVTVDDGWNPATEPEVPGVPWLPVRVELGTVVIGPYVVPGRPGCARCARTRRTRALGPDSPRAELVRRHGDRLADRDTPLLPAPARDTVAALVTHELTSGEHRLTDRAVLMLALPALTAGVHPFLPVPDCPSCGGLPPDRPPVLMDVPRPKPAPDVHRTRDLAAGWDALRDTFVDGRTGVVRQLDVRTDYPYPMVSAPLHLPGGEQEAGFGRDLDYASCARTALAEALERLGGARPGGRRPTVRAPYRDVAGHALHPPDLGLYPPERYAEPGFPYPPFDPGLELSWVWGHSFARDAPVLVPEDYAYYRTRHDGPHARPLAYEVSNGCALGGCLEEAALHGLVELAERDAFLLTWYARLPVPRIDLGTVSDPRIPVLAERIRQDGGHRVVAFATTPDHGVPSVWVMAVHPRPGREPAAVCAAGAHFDPERALLNGLLELTANLGWNRVAWREETARIAAMVDDPELVREMRDHALLYCHPAAFDRFGFLFGDAPALPVREAFARAGLRPRGDDLRDDLAEVVARFTGAGLDVVVVDQTTDEHRAGGFACAKVIVPGLLPMTFGHRMRRTHGLPRLRDLPARLGHRAGPLGPDDVNPHPHPFP	MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSVGSLVETFLPWFGLFVPVLAAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTARDLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDYGPLADTKPADVTMAGNRALRTTVATERGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWALGEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQILVRGVEPTGSWTLPATGSDHLPVAAGVSW	196.06	gnl|BL_ORD_ID|2036|hsp_num:0	2240			771	897	teicoplanin
BGC0001145.1|Cyclothiazomycin_5 # 6264 # 8861 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.773	BGC0001145.1|Cyclothiazomycin_5 	6264	8861	+	Loose	525	28.1054	DHT2-1	34.78	3006872	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	DHT2 beta-lactamase	ATGGACCCGGACTTCTCGACCCCGGACACCTTCGGCGTGCGCGTCGGCGGGCTCCCGGTGGCGGCGCTGGACGCGATGCGCTCCCCCGCGCTGTGGGAGCGGGTGGAGGCGGTGCTCGACGGCGACGAGCGGCTCGCCGCGCGGGCGGCGGAGCTGTCGGACGCCCTCTTCGCGGCGATCGGGCGGACGGCGGAGGGCCGGCCGGCGCTGGTCGCCCTGCGCCGCGCCGTGCACAACCGGAAGCCGCTCACCGACCGGTGCTGGAACGACTCCGTCCGCGCCCTGCTGCCGGCCGCCGTCACCGAGGGCGTCCACGCCTGGCTGCGGCTCCGCGAGGAGCACGAGCGGGACCGGGCGCGCCTCGCCGAGCAGGTGGAGCACCACGCCCGCACCCGGCACGTCCCACTCCGGAAGGCCGTGAGCGACCCGGCGTTCCGGCACGGTCTGGTGCTGAGCAGCCCGGATCTCCACGCCGACGTGTGCCGGTGGCTGGCCCGGCCGGAGGAGACGGTCCCGGACCGCCGGCTGGCGCTGCGGCTGACCAAGTACCTCTCCCGCGTCGCCCTCAAGACCACCCCGTTCAGCACGTTCACCGTCAGCGGTCTGGGGACCTGGCGGGACGGGCCGGTGGCCGGGCCCCCGGCCCCGCCCGCGGTGCGGACCGTGGCGGAGGTCAACATCTGGGTGGTGCAGCAGTTCGTCCGGGAGCTGTCCCGGCATCCGGCGCTGGCGCCCGGGGTCCGGCTGCGGCTCAGCCCGGCCGCGCTGCGCACCGGCGACCGGTGGGAGTTCCTCGGTCCCGGGCCCGAGGAACCGCTGCGCGGCCTGGCCGCCTCCCCGCCGGTCCGGGCGTGCGTGGACGCGGTGGCCGGCGGACGGACGCGGGCGGAGGCGGCCCGGCGGGTCGCGGAGCTGACCGGCGGCACCCCGGAGGCGGCCACCGCCTACCTGGACAAGCTGGTCGAGCTGGGGCTGCTGGAGGCCGAACGGCCCTTCCCCGACCAGGATCCCGATCCGCTGGGGGCGCTCCACGCGTGGGTGTCCGGCGCCGGCCTCTCCGACCTCGGCGCCGAAATCGCCTCCCTCGCGGCGCGGTTGGACGCGTACCCGACGCTCACCGATCCGGCGGACCGGCTCGCGAGCGTCCGGGGCGTCGAGTCGGCGCTGGGCCGCGTCGCGGCCCTCGTCGGCCCGGAGCGGGTGGCGCTGCCCGGCAAGAACAGCGTCGTCGAGAACGCCCTGCTCGTGCCCCCGTCCACCGCCCTCGACCGCCGGGCCTGGGACCCGGTGCTCCGCGACCTGGACGTCGTCCGCCGGCTGCACGGCGTGCTGGACCCCGCGCAGCCGGGCCGGATCGCGCTGGCCGACCTCGTCGCCGAGCGCGTCGGGCCCGGGGCCGCGATGCCGTTCCTGGCCTTCCACCGGACGGTGCAGGGCTGGGTGCGCGAGGATCCCGGCCTGCTGGACGTCCTGTCCGTCACCACGCACGGCTACCGCGCCCTGTCCGGCCACCGGCTGCCGCGCCTCAGGGAACTGGCCCGGCTGCGCGCCGAGTTGTGCGCGGAGGCGCTGGACGGACGGCCGGACGCGGGCGGCGTCCTGCGGCTCGACCCCGGCCCGCTCGCCGCGCGCGCCGCCCGCTGGCCGCACTGGCTGCGCCCGCCGGACTCCGTGACGTACTACGGCCAGCCGCTCGGCGACCCGGCGGACCCCGGCTTCGTCGTCAACGCCGTCAACTCCGGCCACGGGCGCGGGCGCGACCGGATCCGGCGGCTGCTCGCCCAGGCCGGGACCGCCGCGGACGCGCACACCGCGCCGCCGCCCGACGGCGTCCTCGTCGCGGACACCTGCCGGCACTACGGGAGCAACGTGGGGCTGCGGTGTTCGGCGGTGGCCGACGAGATCGACGTCCCCGGCGGCTGGAGCCGCCGCCCGGCGGAGCACCGGATCCCGCTGGGCGACCTGGAGGTGCGGCACGACCCGGAGGCGGGTCTGCTCGTGCTCCGCTCCCTGGCGCGCGGTGTCGAGGTGCGGCCCGTGCACCCCAACCTCATCGCGGAGATGTGGCTGCCGCCCGCCGTCCGGCTGCTCCTGCAGGTGTTCGGCGCGACGTCCAACCTGCTGATCCCCGGCCGGCGGATGTTCGGCGACACCTCGCCGTCCCTGGTGCGGGAGTTGCGGTCCGAGCCGCGGGTGGTGGTCGGGCGGACGGTGGTGAGCCGCCGCCAGTGGGTGTTCCCCGCCGGTGCCGCGCCGGCGCGGCGGCCCGGCGAGGGCGACGCGGCGTACCTGACGCGCCTGGCCGGCTGGCTGCGCGCGCACGGCATGCCGCGGCGCTGCTTCGTCCGGGCCCTGGACCCCGGCGCGGTGGCCGACGGCAGTGTGTGGCGGGTCAAGTCCCGCAAGCCGCTGGCCGTGGACTTCGCCAACCTCCTGCTGGTCGGCCTGTTCGAGCGGATGCTCGCCGAGCCGGACCACGTCCTGTTCCTCCAGGAGGCGCTGCCCGACGCGTCCGGCCTGCCGGACCACGGTGACGGCGCGCCCCGGGTGACCGAATACCTCATCGAGATCAACGGAGGCCGGCATGCCGACCGCTAG	MDPDFSTPDTFGVRVGGLPVAALDAMRSPALWERVEAVLDGDERLAARAAELSDALFAAIGRTAEGRPALVALRRAVHNRKPLTDRCWNDSVRALLPAAVTEGVHAWLRLREEHERDRARLAEQVEHHARTRHVPLRKAVSDPAFRHGLVLSSPDLHADVCRWLARPEETVPDRRLALRLTKYLSRVALKTTPFSTFTVSGLGTWRDGPVAGPPAPPAVRTVAEVNIWVVQQFVRELSRHPALAPGVRLRLSPAALRTGDRWEFLGPGPEEPLRGLAASPPVRACVDAVAGGRTRAEAARRVAELTGGTPEAATAYLDKLVELGLLEAERPFPDQDPDPLGALHAWVSGAGLSDLGAEIASLAARLDAYPTLTDPADRLASVRGVESALGRVAALVGPERVALPGKNSVVENALLVPPSTALDRRAWDPVLRDLDVVRRLHGVLDPAQPGRIALADLVAERVGPGAAMPFLAFHRTVQGWVREDPGLLDVLSVTTHGYRALSGHRLPRLRELARLRAELCAEALDGRPDAGGVLRLDPGPLAARAARWPHWLRPPDSVTYYGQPLGDPADPGFVVNAVNSGHGRGRDRIRRLLAQAGTAADAHTAPPPDGVLVADTCRHYGSNVGLRCSAVADEIDVPGGWSRRPAEHRIPLGDLEVRHDPEAGLLVLRSLARGVEVRPVHPNLIAEMWLPPAVRLLLQVFGATSNLLIPGRRMFGDTSPSLVRELRSEPRVVVGRTVVSRRQWVFPAGAAPARRPGEGDAAYLTRLAGWLRAHGMPRRCFVRALDPGAVADGSVWRVKSRKPLAVDFANLLLVGLFERMLAEPDHVLFLQEALPDASGLPDHGDGAPRVTEYLIEINGGRHADR	MSSIVRGVRAAVVASAISLAAAFACLPLAAADATREPVLPQSGRYEVPDSWRQPIAPVRIADHTWYIGTENLSAVLVTTPQGAVLIDGGMPQAADMLLQRMRDVGIAPGDLRWILVSHAHADHAGPVAKVKRATGARIAANAESAAMLARGGTDDIHFGDDITFPPAQADRLLQDDEVVQVGGIALTGHVTPGHTPGSTSWTWTDTKDGKPVRIAYADSLSAPGYKLIGNPRMPRIVEMYEATFAKVRALPCDLLLTPHPDASGWTPADAANPHPSPKTCAAYADEMEAKFDAELAKQRAAK	286.42	gnl|BL_ORD_ID|3515|hsp_num:0	4584			654	792	
BGC0001145.1|Cyclothiazomycin_9 # 12062 # 12607 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.718	BGC0001145.1|Cyclothiazomycin_9 	12062	12607	-	Loose	400	30.8018	MexL	24.64	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGCACCAACGACAGGGCGCCGCGTCGGGCCTCGCGCGCCGTGCGGGAGTCGTGGGGGCGGCGGCGTTCATCGCCGTCGTCGGCGGCGTGTCGACGGCGGGAGCGGCGACTCCCGGCCCGGGCTCGGACCAGGTCCTCGCCAAGACGGAGTACACGTTCCACCCGGCGGGCCAGGACAGGTCCGTCGCCGCCTCGCGGCGGGTCATCCACTGCGAGATGGTCTTCGTCGGAGCCAACCACGGCGCGCCGCACCACTCCGGTCACGTGCCGGGCACGGTCAACGTCCGGGTCCGCGTGACCTGTACCCAGCCGGTGCGGCTGATCAAGGGGAAGGTCGGTCTCTTCAGCAACCACGGCTCGAAGATCAAGGAGTACGGCAGCACCGGCCGGGCCGCCGCCAAGGGCAACGCGGCCCTCGTCTGCCGGTCCGGCTACTACCAGGGCGAGTCGGCCGCCAGGATCGTCGCGCCGGTCGGCTACAACCCGCCCACCGCGGACATGGCGGCCAGGACCGCCAAGGTGCACCTGACGAAGTGCAGCTGA	MKHQRQGAASGLARRAGVVGAAAFIAVVGGVSTAGAATPGPGSDQVLAKTEYTFHPAGQDRSVAASRRVIHCEMVFVGANHGAPHHSGHVPGTVNVRVRVTCTQPVRLIKGKVGLFSNHGSKIKEYGSTGRAAAKGNAALVCRSGYYQGESAARIVAPVGYNPPTADMAARTAKVHLTKCS	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	85.38	gnl|BL_ORD_ID|4690|hsp_num:0	2219			375	582	erythromycin; tetracycline; triclosan
BGC0001145.1|Cyclothiazomycin_10 # 12919 # 15726 # -1 # ID=1_10;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.786	BGC0001145.1|Cyclothiazomycin_10 	12919	15726	-	Loose	390	31.5722	evgA	32.61	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCGTCGGTCGGCGCGACCGGTCGGGGGAGCGAACTGGCCCGCTTGGCGGGCCTGTTCGACGAGGCTCGCGCGGGGCGGCCGGTCACCGTCCTGGTCCGGGGCGAACCGGGAGCCGGGAAGTCCGCCCTGCTGGAGGCGGCCGCCGGGCTCGCCGCCGCCGCGGGCTTCCACGTGGCCGTGGGCGACGCGCGCGGCCTGCCCGACAGACCGTTCGCCGCCGCGGGCTGCCTGCTCGACCGGTTACCCGGCCCGGGGGATCAGGACCGGGCGCAGGCCCCCGCCCCCGGTGCCGACCCCCTGGGCGAACTCGTGGAACGGGCCCGGCGGCAGGCCGCCCGCGCGCCCGTGGCCCTGTGCCTGGACGACGCGTCCCGGTTGGACACCGGGTCGCTGCGCTGGTTACTCGCCCTGTCCCGGAGCATGCCGCCGGCCCGGCTGGCGATCGTGCTGGCGGCCCGGGACCTGGCCACGGCCCCCGGAGCCGAATTCGCCGTCGCAGCGGAGGTCCTCGACCTCACCGGCCTGCCGGCCGACGCCGTCACCCCCTTCGCCGAGACCCGCTGCGGGGTCTCCCTCGACGCGGCGGCCGCCCGGGCCTGTCACGAACTGACCGGCGGCAACCCGGCGTTGCTGCTGGCCCTGCTGGCCGGACGATCGGGATCCGCGCCCGCCCCCGACGACCTGCGCCCCGCCCCCGGCGCCGCCGCGCTCCCCGGAGCCGAGCGCTGGCTCGGCGGACTCACCCGCCCGGCCCTCGAACTGGCCCGGGCCGTCGCCGTCCTCGGCGCCGACGCCGAGATCACCCAGGCCGCCCGGCTCGCCGGCCTCGACGTCGGGGAAACGCTGCCGGCCGTCGACGAACTGGTCGGCCGATGTCTGCTCGCCAACCGCACCCCCCTGACCTTCCGGCATCCGCTGCTCGCGACCATGGTCACCGAGCGGATCCCCGCCGGCACCCGGGCCGCCCTGCACCTGCGGGCGGCCGAACTGTTGCGGGACGGCGGTTTCGGCGCCACCCGGGTGGCCCGGCACCTCGTCGCGGCGGGACCGCTCGGCCTGAGCTGGACCGTCGAACCCCTGATGACGGCCGCCCGCCGACTGGCCGGCGAGGGCAGGACGGAGGAGGCGGCCCAGCACCTCCGCGGCCTGCTCCGCGAACGGCTGCGCCCCCGCGTGCGGGCGGCCGTCCGCTGTGAACTCGCCCGGCTGGACGGGTTCGTGAACCCCGACCGCGCCATCCGGCTGCTGGACGCCGCCCGGCGCGAGGCCGAGGACCCCGCGGTCGCCACCGACTACGCCCTCGACCTGGCCGCGCTGCTGGCCGGCTGCGGCAGACCGGTGGACGCGGTGGCCGTCCTCGACGACACGGCCGACCGGATCGGCCCGGCCGCGCCCGGGCAGCTCCGGAGACTGCGGCTGCACCGCGCGCTCGTCCGCGTGGCCGGTCCGGCCCGGCTGTTCCCGGAACGCGAACGGCCCGACGGCGCGCCCGCCGACGAGGCCGGGACCGCCGGAGCCGTGGATCCCCCGGACGCCCCGGAATCACCGCACTCACCGCACTCACCGGACGTCCCGGACTCCCCGGACACCGCCGGCCGGCCCGCCGCCCTGCGCGCCGTACACGCCGTCCGCGCCGGCGAGGACCGTGCGGGCGCCGTCCGGTACGCCCGCGAGGCGCTGGCCGCCGGCGGGGACGGCGGCACGGCCACCGTCCTCTGGTACGGCTGCCGCACCCTGATCCACGCCGACGAACTGACCGAGGCGGCGACCTGGTGCGGGCGCTACCGGCCGGTCCGCGGGGCCCGGCCGGGGCGGTGGACGGACGTCGCCGTGGACCTGCTCCGGGCCACGGTCCGCCGGGTCCGCGGCGACCTGCCGGGCGTGATCGAGATGCTGGCGCCCCTGACCGAGCCGCTGTGTACGGAGCCGGGCGCGTCGCACGTGCTCGCCCGGCTCGCCGTCGCCGCCCTGATCGAGGCCGGCGCCATGGCCGGCGACACGGACACCGCGCGGACGCTGCTGACCCGGTGGGGGCTGGACGGCGAACAGCGGCCCCGGCAGGACACGGTGGGGGTGCTGGCCGCCCGCGCCGTCCTCCGGTCGCGGACCGGCGAGGTGCCGGGCGCGGTGGAGGACTGGTACACGGCCGGCCGGATGCTCACCGAACTCGGCGTGCGCAACCCGGCGGTCCTGCCCTGGCGGTCCCGGGCGGCCCACCTGCTGGCCGCCGAAGGGGAGACCGCCGAGGCCGCCCGCCTGGCCCGCGCCGAACTGGAGGACGCCCACCGCTGGGGCACGCCCCGGGCCGTGGGCACGGCCCTGCACGCCGTCGCGATGACGGAGACCGGGCCGCGCCGGATCGAACTCCTCGACAGCGCCGTCGCCCTGCTCGGCCGCTCGCCCGCCCGGCTCGGCGTCGCGGCGGCCCGGCTCGACCTCGGACGCGCCCTCGGCGCCGCCGGCCGTGCGGAGGAGGCGTGCGACGCGTTCACAGCCGCGTCCGCCGGAGCCGAGAGCTGCGGCGCCCGTCCCCTGGCCCGGCGGATCGCGGCGGCGCGCCGGGAGATGTGCCCGACGGAGGAGCGTGAGACCCTGCCGGCGACCCTGACCGGCCTGACCCCGCAGGAACTCCGCATCCTCTCCCTGGCCCGCGACGGCCACACCAACCGGGAGATCGCCGGCCGGCTCTTCGTCACCCTCCGGACCGTGGAGTTCCACCTCTCCGGCGCCTACCGCAAACTCGGCATCTCGGGCCGCCGCCAGCTCGCCGAGGTCATGCCGGCGGAGTCCCGGACGCCCGCGTGA	MASVGATGRGSELARLAGLFDEARAGRPVTVLVRGEPGAGKSALLEAAAGLAAAAGFHVAVGDARGLPDRPFAAAGCLLDRLPGPGDQDRAQAPAPGADPLGELVERARRQAARAPVALCLDDASRLDTGSLRWLLALSRSMPPARLAIVLAARDLATAPGAEFAVAAEVLDLTGLPADAVTPFAETRCGVSLDAAAARACHELTGGNPALLLALLAGRSGSAPAPDDLRPAPGAAALPGAERWLGGLTRPALELARAVAVLGADAEITQAARLAGLDVGETLPAVDELVGRCLLANRTPLTFRHPLLATMVTERIPAGTRAALHLRAAELLRDGGFGATRVARHLVAAGPLGLSWTVEPLMTAARRLAGEGRTEEAAQHLRGLLRERLRPRVRAAVRCELARLDGFVNPDRAIRLLDAARREAEDPAVATDYALDLAALLAGCGRPVDAVAVLDDTADRIGPAAPGQLRRLRLHRALVRVAGPARLFPERERPDGAPADEAGTAGAVDPPDAPESPHSPHSPDVPDSPDTAGRPAALRAVHAVRAGEDRAGAVRYAREALAAGGDGGTATVLWYGCRTLIHADELTEAATWCGRYRPVRGARPGRWTDVAVDLLRATVRRVRGDLPGVIEMLAPLTEPLCTEPGASHVLARLAVAALIEAGAMAGDTDTARTLLTRWGLDGEQRPRQDTVGVLAARAVLRSRTGEVPGAVEDWYTAGRMLTELGVRNPAVLPWRSRAAHLLAAEGETAEAARLARAELEDAHRWGTPRAVGTALHAVAMTETGPRRIELLDSAVALLGRSPARLGVAAARLDLGRALGAAGRAEEACDAFTAASAGAESCGARPLARRIAAARREMCPTEERETLPATLTGLTPQELRILSLARDGHTNREIAGRLFVTLRTVEFHLSGAYRKLGISGRRQLAEVMPAESRTPA	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	458.33	gnl|BL_ORD_ID|936|hsp_num:0	1015			420	558	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
